Multimodal imaging of Hurler syndrome-related keratopathy treated with deep anterior lamellar keratoplasty.

Case report Deep anterior lamellar keratoplasty Hurler syndrome In vivo confocal microscopy Optical coherence tomography

Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
31 Oct 2020
Historique:
received: 14 07 2020
accepted: 08 10 2020
entrez: 1 11 2020
pubmed: 2 11 2020
medline: 15 5 2021
Statut: epublish

Résumé

Hurler syndrome-associated keratopathy is an exceedingly rare corneal disorder that requires corneal transplantation in advanced stages. Precise assessment of the corneal condition is necessary for deciding which type of keratoplasty (i.e., deep anterior lamellar or penetrating) should be proposed. We aimed to confront the results of multimodal imaging with those of histology in a case of Hurler syndrome-associated keratopathy. A 16-year-old patient with Hurler's syndrome treated with hematopoietic stem cell transplantation was referred for decreased vision related to advanced keratopathy. The patient was treated with deep anterior lamellar keratoplasty (DALK) in both eyes with uncomplicated outcome. Visual acuity improved from 0.1 (20/200) preoperatively to 0.32 (20/63) and 0.63 (20/32) after transplantation. The corneal endothelial cell density was 2400 cells/mm The observed corneal multimodal imaging features in mucopolysaccharidosis-related keratopathy were concordant with histology. Compared with standard histology, multimodal imaging allowed additional keratocyte features to be observed. It revealed both morphological and structural changes of all corneal layers but the endothelium. This information is essential for therapeutic management which should include DALK as the first-choice treatment in case of impaired visual acuity.

Sections du résumé

BACKGROUND BACKGROUND
Hurler syndrome-associated keratopathy is an exceedingly rare corneal disorder that requires corneal transplantation in advanced stages. Precise assessment of the corneal condition is necessary for deciding which type of keratoplasty (i.e., deep anterior lamellar or penetrating) should be proposed. We aimed to confront the results of multimodal imaging with those of histology in a case of Hurler syndrome-associated keratopathy.
CASE PRESENTATION METHODS
A 16-year-old patient with Hurler's syndrome treated with hematopoietic stem cell transplantation was referred for decreased vision related to advanced keratopathy. The patient was treated with deep anterior lamellar keratoplasty (DALK) in both eyes with uncomplicated outcome. Visual acuity improved from 0.1 (20/200) preoperatively to 0.32 (20/63) and 0.63 (20/32) after transplantation. The corneal endothelial cell density was 2400 cells/mm
CONCLUSIONS CONCLUSIONS
The observed corneal multimodal imaging features in mucopolysaccharidosis-related keratopathy were concordant with histology. Compared with standard histology, multimodal imaging allowed additional keratocyte features to be observed. It revealed both morphological and structural changes of all corneal layers but the endothelium. This information is essential for therapeutic management which should include DALK as the first-choice treatment in case of impaired visual acuity.

Identifiants

pubmed: 33129306
doi: 10.1186/s12886-020-01689-2
pii: 10.1186/s12886-020-01689-2
pmc: PMC7603712
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

433

Subventions

Organisme : ANR PRTS
ID : ANR-13-PRTS-0009

Références

Ophthalmology. 2010 Nov;117(11):2191-5
pubmed: 20663562
Arq Bras Oftalmol. 2020 Mar-Apr;83(2):98-102
pubmed: 32159591
Cornea. 1992 Jan;11(1):86-92
pubmed: 1559353
BMJ Case Rep. 2014 Apr 04;2014:
pubmed: 24706723
Exp Eye Res. 1996 Apr;62(4):377-87
pubmed: 8795456
J Fr Ophtalmol. 1989;12(8-9):561-8
pubmed: 2517542
Br J Ophthalmol. 2011 May;95(5):613-9
pubmed: 20852315
Br J Ophthalmol. 2003 Feb;87(2):225-36
pubmed: 12543757
Arch Ophthalmol. 2011 Feb;129(2):138-44
pubmed: 21320956
Surv Ophthalmol. 2018 May - Jun;63(3):365-380
pubmed: 28801092
J AAPOS. 2008 Feb;12(1):7-10
pubmed: 17588792
Cornea. 2003 Jan;22(1):76-9
pubmed: 12502956
Orphanet J Rare Dis. 2008 Sep 16;3:24
pubmed: 18796143
Ophthalmology. 1998 Jun;105(6):1099-105
pubmed: 9627663
Hum Mutat. 1995;6(4):288-302
pubmed: 8680403
Arch Ophthalmol. 2008 Jan;126(1):31-7
pubmed: 18195215
Cornea. 2019 Mar;38(3):376-378
pubmed: 30575621
Surv Ophthalmol. 2006 Jan-Feb;51(1):1-17
pubmed: 16414358
Exp Eye Res. 1999 May;68(5):523-30
pubmed: 10328965
Genet Med. 2005 Feb;7(2):143-6
pubmed: 15714083
Expert Opin Pharmacother. 2005 Mar;6(3):489-506
pubmed: 15794739
J Pediatr Ophthalmol Strabismus. 2013 Nov-Dec;50(6):376-81
pubmed: 24669375
Cornea. 2014 Jan;33(1):35-42
pubmed: 24212765
Eye (Lond). 2014 Mar;28(3):327-36
pubmed: 24384963

Auteurs

Elodie Da Cunha (E)

GRC32, Transplantation et Thérapies Innovantes de la Cornée, Sorbonne université, Centre Hospitalier National d'Ophtalmologie des 15-20, 28 rue de Charenton, 75571 Cedex 12, Paris, France.

Cristina Georgeon (C)

GRC32, Transplantation et Thérapies Innovantes de la Cornée, Sorbonne université, Centre Hospitalier National d'Ophtalmologie des 15-20, 28 rue de Charenton, 75571 Cedex 12, Paris, France.

Nacim Bouheraoua (N)

GRC32, Transplantation et Thérapies Innovantes de la Cornée, Sorbonne université, Centre Hospitalier National d'Ophtalmologie des 15-20, 28 rue de Charenton, 75571 Cedex 12, Paris, France.

Marc Putterman (M)

Laboratoire (2), Centre Hospitalier National d'Ophtalmologie des 15-20, Paris, France.

Françoise Brignole-Baudouin (F)

Laboratoire (2), Centre Hospitalier National d'Ophtalmologie des 15-20, Paris, France.

Vincent M Borderie (VM)

GRC32, Transplantation et Thérapies Innovantes de la Cornée, Sorbonne université, Centre Hospitalier National d'Ophtalmologie des 15-20, 28 rue de Charenton, 75571 Cedex 12, Paris, France. vincent.borderie@upmc.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH